This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesolf) to predict amikacin dose requirements in 10 patients with haematological disease and neutropenic fever. OPT-determined dose adjustment achieved therapeutic drug levels for 80% of the peak and 94% of the trough measurements.
|Original language||English (US)|
|Number of pages||2|
|Journal||South African Medical Journal|
|State||Published - Dec 1 1993|
ASJC Scopus subject areas